Comparison of tissue reaction and osteointegration of metal implants between hydroxyapatite/Ti alloy coat: an animal experimental study.
ABSTRACT One important clinical application of hydroxyapatite (HA) is coating on metal implants to stimulate osteo-integration thus enhancing fixation of the implant to bone, especially plasma-sprayed HA coating applied on Ti alloy substrate. The poor bonding strength between HA and Ti alloy has been of great concern to orthopedists. The biocomptable coat such as Ti alloy (TiO2) coat is one method to improve adhesive strength.
The objective of this study was to detect and analyze possible differences in bone formation, bone integration and tissue reaction between group I (uncoated Titanium), group II (Hydroxyapatite coated Titanium), and group III (Hydroxyapatite/TiO2 coated Titanium) implant specimens when embedded into bony hosts.
Rectangular specimens were implanted into the femoral bone of adult dogs in randomly different sites including: proximal left, proximal right, distal left, distal right. The tailor-made implant specimens were inserted in 5 x 5 mm preprepared sockets. Radiographic evaluation was taken at 0, 1, 3 and 6 months. All animals were sacrificed at 3 and 6 months post implantation. The femoral bone containing implants were dissected and then prepared to be further investigated. The bone-implant interface was analyzed by H&E surface staining, radiography and scanning electron microscopy. Data concerning percentage of osteointegration and adhesiveness of hydroxyapatite layer from different kinds of implants along the entire length of each implants were collected and analyzed for evaluation of any significant differences.
No osteo-integration was noted in Group I, but there was 25.57 per cent osteointegration in Group II and 28.63 per cent in Group III. No statistically significant differences were observed between Group II and Group III. However, the coating layer in Group II was found to have detached, in some area, from the metal substrate. Histologically, no adverse tissue reaction was found around any kind of implant.
Biocompatable bond coat is one of the methods to improve adhesive strength of hydroxyapatite coated implants. In the present study it could be concluded that, besides the improvement in adhesiveness, the intervening TiO2 coating layer had no negative effect concerning bone formation and integration and also showed no adverse surrounding soft tissue reaction.
- [Show abstract] [Hide abstract]
ABSTRACT: Hydroxyapatite and 'duplex' hydroxyapatite + titania bond coat layers were deposited onto Ti6Al4V substrates by atmospheric plasma spraying (APS) at moderate plasma enthalpies. From as-sprayed coatings and coatings incubated in simulated body fluid (r-SBF) electron-transparent samples were generated by focused ion beam (FIB) excavation and investigated by STEM/TEM in conjunction with energy-dispersive X-ray analysis (EDX), electron diffraction (ED), and electron energy loss spectroscopy (EELS). Adjacent to the metal surface a thin layer of amorphous calcium phosphate (ACP) was deposited whose Ca/P ratio is determined by the presence or absence of the bond coat. No clear indication of a Ca-Ti oxide reaction layer was found at the interface titania bond coat/calcium phosphate. After in vitro incubation of duplex coatings for 24 weeks Ca-deficient defect apatite needles precipitated from ACP. During incubation of hydroxyapatite without a bond coat for 1 week diffusion bands were formed within the ACP of 1-2 microm width parallel to the interface metal/coating, presumably by a dissolution-precipitation sequence.Biomaterials 03/2006; 27(6):823-31. DOI:10.1016/j.biomaterials.2005.06.029 · 8.31 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Hydroxypropyltrimethyl ammonium chloride chitosan (HACC) was synthesised with differing degrees of substitution (6%, 18% and 44%) of quaternary ammonium by reacting chitosan with glycidyl trimethylammonium chloride. The antibacterial activities of these polymers were tested in vitro against Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus, and Staphylococcus epidermidis. Mouse fibroblasts and bone marrow derived stromal cells (hMSCs) were used to investigate the biocompatibility of the HACC. The results show that the antibacterial activities of the HACC with 18% or 44% substitution were significantly higher than the others (P < 0.05) against all three bacteria. HACC with 6% or 18% substitution was not cytotoxic and did not interfere with the proliferation and osteogenic differentiation of hMSCs. Overall, we can make a conclusion that HACC with an 18% substitution was a potential pharmaceutical that can inhibit the growth of bacteria and has good biocompatibility with osteogenic cells.Carbohydrate Polymers 06/2010; 81(2-81):275-283. DOI:10.1016/j.carbpol.2010.02.008 · 3.92 Impact Factor